The Conversation U.S. on Nostr: The U.S. Drug Enforcement Agency announced recently that it plans to ease ...

The U.S. Drug Enforcement Agency announced recently that it plans to ease restrictions on cannabis – reclassifying it from a Schedule I drug to a Schedule III drug, a category which includes products like Tylenol with codeine, testosterone and other anabolic steroids.

This is a historic shift, signaling an acknowledgement of the promising medicinal value of cannabis 🌿
https://theconversation.com/how-cannabis-and-psilocybin-might-help-some-of-the-50-million-americans-who-are-experiencing-chronic-pain-225887